Nuzenio

Therapy Designation

Therapy Designation news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 21 latest news signals 19 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 12:50:07 GMTFDA Grants Breakthrough Therapy Status to a Pancreatic Cancer Drug for a Mutation Found in Roughly 1 in 50 Patients - medicaldaily.com
Thu, 06 Aug 2026 11:15:00 GMTOcugen Reports Q2 2026 Results, Advances OCU410 Phase 3, Secures RMAT Designation and $130 Million Financing - Quiver Quantitative
Wed, 05 Aug 2026 13:26:29 GMTFDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - Oncodaily
Wed, 05 Aug 2026 11:00:00 GMTLexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation For LX2020 For The Treatment Of PKP2 Arrhythmogenic Cardiomyopathy - marketscreener.com
Tue, 04 Aug 2026 19:15:28 GMTFDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -
Tue, 04 Aug 2026 18:53:00 GMTFDA Grants Breakthrough Therapy Status to Eli Lilly's Pancreatic Cancer Treatment - Investing News Network

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Therapy Designation.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

19 distinct publisher/source names are currently connected to this entity page.